Clinical trials
Glioma trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Novartis Pharmaceuticals | 4 |
| Universitaire Ziekenhuizen KU Leuven | 4 |
| Eli Lilly and Company | 2 |
| Actuate Therapeutics Inc. | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Amgen | 1 |
| BBB-Therapeutics B.V. | 1 |
| Basilea Pharmaceutica | 1 |
| Erasme University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 27 |
| Astrocytoma | 10 |
| Brain Neoplasms | 10 |
| Glioblastoma | 9 |
| Oligodendroglioma | 9 |
| Central Nervous System Neoplasms | 7 |
| Neoplasms | 5 |
| Biliary Tract Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Diffuse Intrinsic Pontine Glioma | 2 |
Trials
Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.